Parathyroid Hormone and Parathyroid Hormone-Related Protein Analogs in Osteoporosis Therapy.

about

Osteoprotection Through the Deletion of the Transcription Factor Rorβ in Mice.

P2860

Q47329687-42EAC9BB-8F3E-4F07-AB4E-F9CEB03411A0

P2860

Parathyroid Hormone and Parathyroid Hormone-Related Protein Analogs in Osteoporosis Therapy.

Item

http://www.wikidata.org/entity/Q39183207

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Parathyroid Hormone and Parath ...... alogs in Osteoporosis Therapy.

@en

Parathyroid Hormone and Parath ...... alogs in Osteoporosis Therapy.

@nl

type

Item

label

Parathyroid Hormone and Parath ...... alogs in Osteoporosis Therapy.

@en

Parathyroid Hormone and Parath ...... alogs in Osteoporosis Therapy.

@nl

prefLabel

Parathyroid Hormone and Parath ...... alogs in Osteoporosis Therapy.

@en

Parathyroid Hormone and Parath ...... alogs in Osteoporosis Therapy.

@nl

P1476

Parathyroid Hormone and Parath ...... alogs in Osteoporosis Therapy.

@en

P2093

Benjamin Z Leder

http://www.w3.org/2001/XMLSchema#string

P2860

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

Denosumab for prevention of fractures in postmenopausal women with osteoporosis

Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis

Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trial.

Two years of Denosumab and teriparatide administration in postmenopausal women with osteoporosis (The DATA Extension Study): a randomized controlled trial.

Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial.

Effects of Two Years of Teriparatide, Denosumab, or Both on Bone Microarchitecture and Strength (DATA-HRpQCT study)

Daily or Cyclical Teriparatide Treatment in Women With Osteoporosis on no Prior Therapy and Women on Alendronate.

Early responsiveness of women with osteoporosis to teriparatide after therapy with alendronate or risedronate

Parathyroid hormone: anabolic and catabolic actions on the skeleton

P2888

s11914-017-0353-4

P304

110-119

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11914-017-0353-4

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28303448

http://www.w3.org/2001/XMLSchema#string

P921

osteoporosis

P932

5477638

http://www.w3.org/2001/XMLSchema#string

Parathyroid Hormone and Parathyroid Hormone-Related Protein Analogs in Osteoporosis Therapy.

about

P2860

P2860

Parathyroid Hormone and Parathyroid Hormone-Related Protein Analogs in Osteoporosis Therapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P921

P932